As expected, prostate cancer PPC1 cells subjected to Cdk1 knockdown showed G2-M phase arrest; however, Cdk1 knockdown did not sensitize PPC1 cells to Fas or TRAIL (data not shown). Here, CDK1 is linked to prostate carcinoma.